Research map: Photodynamic Therapy in Central Serous Chorioretinopathy: Treatment Timing, Anatomical Response, and Recurrence in a Large Real-World Cohort
Back to the article
Papers in this map
Photodynamic therapy – mechanisms, photosensitizers and combinations
· Stanisław Kwiatkowski · 2018 · 2189 citations · Cited by this paper
Peripapillary Retinal Nerve Fibre and Ganglion Cell Layer Changes Following Intravitreal Aflibercept 8 mg Therapy in Neovascular Age-Related Macular Degeneration: A Longitudinal OCT Study
· 2026 · Related
Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis
· Alejandra Daruich · 2015 · 1000 citations · Cited by this paper
Long-Term Effects of Phacoemulsification with Goniosynechialysis in Angle-Closure Glaucoma: A 2-Year Prospective Cohort Study
· 2026 · Related
Central serous chorioretinopathy: Towards an evidence-based treatment guideline
· Thomas J. van Rijssen · 2019 · 498 citations · Cited by this paper
Aflibercept 24-Month Outcomes in Diabetic Macular Edema With and Without Prior Macular Laser Therapy: Data from the Fight Retinal Blindness! Registry
· 2026 · Related
The Incidence of Central Serous Chorioretinopathy in Olmsted County, Minnesota, 1980–2002
· Anna S. Kitzmann · 2008 · 468 citations · Cited by this paper
Impact of an Ophthalmic Cooling Device on Corneal Immune and Sensory Nerve Features in Chronic Ocular Surface Pain: A Prospective, Feasibility Study
· 2026 · Related
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy
· Elon H. C. van Dijk · 2018 · 356 citations · Cited by this paper
Retinal Vascular Features and Risk of Colorectal Cancer Incidence and Mortality: A Population-Based Cohort Study
· 2026 · Related
Central Serous Chorioretinopathy and Glucocorticoids
· Evrydiki A Bouzas · 2002 · 316 citations · Cited by this paper
Paediatric Keratoconus: An ERN-EYE Clinical Consensus Statement on Diagnosis, Treatment and Follow-Up Care
· 2026 · Related
Central serous chorioretinopathy: An update on risk factors, pathophysiology and imaging modalities
· Rebecca Kaye · 2020 · 258 citations · Cited by this paper
A Multimodal Approach to Open-Angle Glaucoma with Travoprost Intracameral Implant and Minimally Invasive Glaucoma Surgery with or Without Concurrent Cataract Surgery
· 2026 · Related
Uveal effusion syndrome
· M Uyama · 2000 · 217 citations · Cited by this paper
Advances in Polypoidal Choroidal Vasculopathy (PCV) Management: Emerging Evidence for Faricimab and Aflibercept 8 mg
· 2026 · Related
Central Serous Chorioretinopathy
· Raffael Gi-Hwan Liegl · 2014 · 144 citations · Cited by this paper
The Role of Sex in Ocular Biometry: A Large-Scale Study of Cataract Candidates in Greece
· 2026 · Related
Central serous chorioretinopathy: An evidence-based treatment guideline
· Helena M. A. Feenstra · 2024 · 126 citations · Cited by this paper
Real-Life 1-Year Results and Predictors of Visual Outcome with Intravitreal Faricimab for Treatment of Exudative Neovascular Age-Related Macular Degeneration
· 2026 · Related
Central Serous Chorioretinopathy in Women
· David A. Quillen · 1996 · 123 citations · Cited by this paper
Central serous chorioretinopathy: A review
· Adrian Tien-chin Fung · 2023 · 115 citations · Cited by this paper
The Pachychoroid Disease Spectrum—and the Need for a Uniform Classification System
· Jakob Siedlecki · 2019 · 108 citations · Cited by this paper
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial
· Thomas J. van Rijssen · 2021 · 100 citations · Cited by this paper
Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3
· Thomas J. van Rijssen · 2019 · 61 citations · Cited by this paper
Association of Helicobacter pylori with central serous chorioretinopathy: hypotheses regarding pathogenesis
· Cristiano Giusti · 2004 · 60 citations · Cited by this paper
Pathomechanisms in central serous chorioretinopathy: A recent update
· Arman Zarnegar · 2023 · 59 citations · Cited by this paper
Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy
· Mary T. Ho · 2020 · 57 citations · Cited by this paper
Corticosteroids usage and central serous chorioretinopathy: a meta-analysis
· Ge Ge · 2019 · 52 citations · Cited by this paper
TRANSSCLERAL ALBUMIN DIFFUSION AND SUPRACHOROIDAL ALBUMIN CONCENTRATION IN UVEAL EFFUSION SYNDROME
· Timothy L. Jackson · 2011 · 46 citations · Cited by this paper
Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
· Thomas J. van Rijssen · 2021 · 36 citations · Cited by this paper
Incidence and natural course of symptomatic central serous chorioretinopathy in pregnant women in a maternity hospital in Kuwait
· Khaled Said-Ahmed · 2012 · 34 citations · Cited by this paper
Central serous chorioretinopathy and the sclera: what we have learned so far
· Hideki Koizumi · 2024 · 33 citations · Cited by this paper
Perspectives and Update on the Global Shortage of Verteporfin (Visudyne®)
· Marc J. Sirks · 2024 · 24 citations · Cited by this paper
Chorioretinopathia centralis serosa
· Laurenz Johannes Bernhard Pauleikhoff · 2021 · 23 citations · Cited by this paper
Genetic associations of central serous chorioretinopathy: a systematic review and meta-analysis
· Zhen Ji Chen · 2021 · 21 citations · Cited by this paper
Therapies for Central Serous Chorioretinopathy
· Leo A. Kim · 2024 · 19 citations · Cited by this paper
Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy
· Leonie Franziska Keidel · 2023 · 17 citations · Cited by this paper
Central Serous Chorioretinopathy: Epidemiology, Genetics and Clinical Features
· Adnan H. Khan · 2024 · 13 citations · Cited by this paper
Source: OpenAlex (CC0)